DJIA 18,288.63 155.93 0.86%
NASDAQ 5,008.10 44.57 0.90%
S&P 500 2,117.39 12.89 0.61%
market minute promo


2.54 -0.16 (-5.93%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMRS $2.54 -5.93%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.72
Previous Close $2.70
Daily Range $2.49 - $2.72
52-Week Range $1.56 - $5.25
Market Cap $200.9M
P/E Ratio -3.00
Dividend (Yield) $0.00 (0.0%)
Volume 251,088
Average Daily Volume 216,329
Current FY EPS -$0.65




Drug Makers


Amyris Inc. is building a renewable products company by applying its industrial synthetic biology technology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. Website:

News & Commentary Rss Feed

Amyris Inc, Despite Falling Oil Prices, Is Positioned to Benefit from Brazil's Growth and Environmen

Oil prices are falling, but that hasn't stopped Brazil from working toward cleaning the environment and boosting its own economy.

This Next-Generation Biotech Just Set the Stage for a Big 2015

Amyris has a steadily increasing stream of momentum behind it as the next-generation biotech enters 2015.

Amyris' (AMRS) CEO John Melo on Q4 2014 Results - Earnings Call Transcript

Amyris (AMRS) Q4 2014 Results - Earnings Call Webcast

3 Stocks Pushing The Chemicals Industry Lower

3 Risks for My Favorite Biotech Stock in 2015

Amyris is an intriguing pick for anyone's favorite stock, so here are some risks to keep in mind.

British Invasion: Why is America Producing Fuel for This WWII Airplane?

Watch out, petroleum. This British biotech company is fueling the comeback of biobutanol-- something last produced during World War II.

Stocks Hitting 52-Week Lows

1 Big Oil Company That Sees a Future in Renewable Energy

Not many oil companies are betting on renewables, but this French oil giant is betting billions that solar and biotech will be a big part of its future.

This Technology Could Create Cheaper Marijuana Drugs

Plant-based manufacturing has many inefficiencies, but that doesn't mean marijuana drugs are doomed. New technology could create the same cannabinoids -- without the plant.

See More AMRS News...

AMRS's Top Competitors

AMRS $2.54 (-5.93%)
Current stock: AMRS
FCEL $1.33 (1.53%)
Current stock: FCEL
CDXS $3.70 (4.82%)
Current stock: CDXS
RTK $1.37 (0.00%)
Current stock: RTK